Interleukin-18 receptor signaling is not required for autoantibody production and end-organ disease in murine lupus

被引：11
|
作者：
Lin, Ling [1 ]
Peng, Stanford L. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO 63130 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 03期
关键词：
D O I：
10.1002/art.20961
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：984 / 986
页数：3
相关论文
共 50 条
  • [31] Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated Glomerulonephritis
    Fairhurst, Anna-Marie
    Xie, Chun
    Fu, Yuyang
    Wang, Andrew
    Boudreaux, Christopher
    Zhou, Xin J.
    Cibotti, Ricardo
    Coyle, Anthony
    Connolly, John E.
    Wakeland, Edward K.
    Mohan, Chandra
    JOURNAL OF IMMUNOLOGY, 2009, 183 (10): : 6831 - 6838
  • [32] SERUM INTERLEUKIN-18 AND INTERLEUKIN-10 LEVELS IN SYSTEMIC LUPUS ERYTHEMATOSUS: CORRELATION TO SLEDAI SCORE AND DISEASE ACTIVITY PARAMETERS
    Mohammed, R. H. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 986 - 987
  • [33] Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
    Christensen, SR
    Kashgarian, M
    Alexopoulou, L
    Flavell, RA
    Akira, S
    Shlomchik, MJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (02): : 321 - 331
  • [34] Serum interleukin-18 and interleukin-10 levels in systemic lupus erythematosus: correlation with SLEDAI score and disease activity parameters
    Sahar Abou El-Fetouh
    Reem Hamdy A. Mohammed
    Hanan S. Mohmad Abozaid
    Egyptian Rheumatology and Rehabilitation, 2014, 41 (4) : 160 - 166
  • [35] Signaling through the interleukin-18 receptor α attenuates inflammation in cisplatin-induced acute kidney injury
    Nozaki, Yuji
    Kinoshita, Koji
    Yano, Tomohiro
    Asato, Kayo
    Shiga, Toshihiko
    Hino, Shoichi
    Niki, Kaoru
    Nagare, Yasuaki
    Kishimoto, Kazuya
    Shimazu, Hideki
    Funauchi, Masanori
    Matsumura, Itaru
    KIDNEY INTERNATIONAL, 2012, 82 (08) : 892 - 902
  • [36] Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis
    Tsai, Pei-Yi
    Ka, Shuk-Man
    Chang, Jia-Ming
    Lai, Jenn-Haung
    Dai, Ming-Shen
    Jheng, Huei-Lin
    Kuo, Mao-Tien
    Chen, Peini
    Chen, Ann
    ARTHRITIS AND RHEUMATISM, 2012, 64 (01): : 232 - 242
  • [37] Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
    Wang, Hai-Ning
    Wang, Yan-Rong
    Liu, Guo-Qiang
    Liu, Zhe
    Wu, Pei-Xian
    Wei, Xiao-Ling
    Hong, Tian-Pei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (47) : 7240 - 7246
  • [38] Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
    Hai-Ning Wang
    World Journal of Gastroenterology, 2008, 14 (47) : 7240 - 7246
  • [39] Increased Expression of Interleukin-18 and its Receptor in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease
    Wang, Jianmiao
    Liu, Xiansheng
    Xie, Min
    Xie, Jungang
    Xiong, Weining
    Xu, Yongjian
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (04) : 375 - 381
  • [40] Interleukin-18 Increases TLR4 and Mannose Receptor Expression and Modulates Cytokine Production in Human Monocytes
    Dias-Melicio, Luciane Alarcao
    Fernandes, Reginaldo Keller
    Rodrigues, Daniela Ramos
    Golim, Marjorie Assis
    Victoriano Campos Soares, Angela Maria
    MEDIATORS OF INFLAMMATION, 2015, 2015
12345